Wiseman H
Pharmacology Group, King's College, University of London, UK.
FEBS Lett. 1993 Jul 12;326(1-3):285-8. doi: 10.1016/0014-5793(93)81809-e.
Vitamin D is a membrane antioxidant: thus Vitamin D3 (cholecalciferol) and its active metabolite 1,25-dihydroxycholecalciferol and also Vitamin D2 (ergocalciferol) and 7-dehydrocholesterol (pro-Vitamin D3) all inhibited iron-dependent liposomal lipid peroxidation. Cholecalciferol, 1,25-dihydroxycholecalciferol and ergocalciferol were all of similar effectiveness as inhibitors of lipid peroxidation but were less effective than 7-dehydrocholesterol; this was a better inhibitor of lipid peroxidation than cholesterol, though not ergosterol. The structural basis for the antioxidant ability of these Vitamin D compounds is considered in terms of their molecular relationship to cholesterol and ergosterol. Furthermore, the antioxidant ability of Vitamin D is compared to that of the anticancer drug tamoxifen and its 4-hydroxy metabolite (structural mimics of cholesterol) and discussed in relation to the anticancer action of this vitamin.
维生素D是一种膜抗氧化剂:因此,维生素D3(胆钙化醇)及其活性代谢物1,25 - 二羟基胆钙化醇,以及维生素D2(麦角钙化醇)和7 - 脱氢胆固醇(维生素D3原)均能抑制铁依赖性脂质体脂质过氧化。胆钙化醇、1,25 - 二羟基胆钙化醇和麦角钙化醇作为脂质过氧化抑制剂的效果相似,但比7 - 脱氢胆固醇的效果要差;7 - 脱氢胆固醇是比胆固醇更好的脂质过氧化抑制剂,不过比麦角固醇要差。这些维生素D化合物抗氧化能力的结构基础是根据它们与胆固醇和麦角固醇的分子关系来考虑的。此外,还将维生素D的抗氧化能力与抗癌药物他莫昔芬及其4 - 羟基代谢物(胆固醇的结构类似物)的抗氧化能力进行了比较,并就该维生素的抗癌作用进行了讨论。